NAT10 and pancreatic neoplasm: Consistent with our findings, recent studies have reported that a novel lncRNA LINC00623 binds to NAT10 and prevents its ubiquitination-dependent degradation, thus influencing mRNA ac4C modification and expression in pancreatic cancer [23].